1. Testicular plasmacytoma in a patient with relapsed multiple myeloma

   • Dimitrios Pilalas
   • Christos Savopoulos
   • Georgia D. Kaiafa

   Images in Hematology 08 June 2020 Pages: 131 - 133

   

2. Diffuse alveolar hemorrhage during induction therapy for acute myeloid leukemia with inv(16)(p13.1q22)

   • Minoru Kanaya
   • Takeshi Kondo

   Images in Hematology 06 June 2020 Pages: 134 - 135

   

3. Diffuse follicular lymphoma variant with a typical diagnostic pattern and an unusually aggressive clinical presentation

   • Fernando Martín-Moro
   • Juan Marquet-Palomanes
   • Mónica García-Cosío

   Images in Hematology 06 June 2020 Pages: 136 - 138

   

4. An interesting case of thrombocytopenia in pregnancy

   • Alejandro Garcia-Horton
   • Ian Chin-Yee
   • Selay Lam

   Images in Hematology 19 June 2020 Pages: 139 - 140

   

5. High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity

   • Giovanni Caocci
   • Marco Vignetti
   • Fabio Efficace

   Rapid Communication 25 June 2020 Pages: 141 - 146

   

6. The human spleen as the center of the blood defense system

   • Makoto Kashimura

   Review Article 16 June 2020 Pages: 147 - 158

   

7. Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice

   • Masaki Iino
   • Yuma Sakamoto
   • Tomoya Sato

   Original Article 31 May 2020 Pages: 159 - 168

   

8. Characterization of hereditary factor XI deficiency in Taiwanese patients: identification of three novel and two common mutations

   • Hsuan-Yu Lin
   • Ching-Yeh Lin
   • Ming-Ching Shen

   Original Article 24 April 2020 Pages: 169 - 175

   

9. Real-world, retrospective study evaluating thromboembolic events, associated risk factors, and health-care resource utilization in Japanese patients with polycythemia vera

   • Norio Komatsu
   • GyungJin Jun
   • Yasuo Ohashi

   Original Article 11 May 2020 Pages: 176 - 184

   

10. Clinical features and outcomes of adult Langerhans cell histiocytosis: a single-center experience

    • Masayuki Kobayashi
    • Shohei Ando
    • Arinobu Tojo

    Original Article 08 June 2020 Pages: 185 - 192

    

11. T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

    • Masatomo Kuno
    • Ayumu Ito
    • Takahiro Fukuda

    Original Article 29 May 2020 Pages: 193 - 199

    

12. The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse

    • Saiko Kurosawa
    • Hiroki Yamaguchi
    • Takahiro Fukuda

    Original Article 03 June 2020 Pages: 200 - 209

    

13. Busulfan clearance does not predict the development of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation

    • Bushra Salman
    • Murtadha Al-Khabori
    • Mohammed Al-Za’abi

    Original Article 28 May 2020 Pages: 210 - 216

14. Functional characterization of a germline ETV6 variant associated with inherited thrombocytopenia, acute lymphoblastic leukemia, and salivary gland carcinoma in childhood

    • Hiroshi Yoshino
    • Yohei Nishiyama
    • Masatoshi Takagi

    Original Article 04 May 2020 Pages: 217 - 222

    

15. A phase 1b study of blinatumomab in Japanese children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

    • Keizo Horibe
    • Joan D. Morris
    • Chitose Ogawa

    Original Article 20 June 2020 Pages: 223 - 233

    

16. Venetoclax monotherapy induced rapid and sustained response in a frail patient with refractory AL amyloidosis: Less is more?

    • Pui-Lun Yip
    • June S. M. Lau
    • Ching-Pong Lam

    Case Report 23 March 2020 Pages: 234 - 237

    

17. Myeloid neoplasm with isolated del(5q) and the MPLW515L mutation fulfills the WHO diagnostic criteria for ET

    • Keita Kirito

    Case Report 03 April 2020 Pages: 238 - 242

    

18. Successful treatment with gilteritinib for isolated extramedullary relapse of acute myeloid leukemia with FLT3-ITD mutation after allogeneic stem cell transplantation

    • Michiko Kida
    • Yoshiaki Kuroda
    • Takuo Ito

    Case Report 13 March 2020 Pages: 243 - 248

    

19. Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor

    • Toshihiko Ando
    • Haruna Sano
    • Shinya Kimura

    Case Report 17 March 2020 Pages: 249 - 253

    

20. Limbic encephalitis with antibodies to N-methyl-d-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation

    • Jun Toda
    • Tetsuo Maeda
    • Yuzuru Kanakura

    Case Report 21 March 2020 Pages: 254 - 257

    

21. Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation

    • Kunihiko Moriya
    • Tasuku Suzuki
    • Shigeo Kure

    Case Report 16 March 2020 Pages: 258 - 262

    

22. Vascular events may predict the prognosis of patients with chronic myeloid leukemia

    • Hiroshi Ureshino
    • Kazuharu Kamachi

    Letter to the Editor 12 June 2020 Pages: 263 - 263

23. Effect of age and comorbidities on the decline of glomerular filtration rate in chronic myeloid leukemia patients discontinuing tyrosine kinase inhibitors

    • Marko Lucijanic
    • Ivan Krecak

    Letter to the Editor 09 June 2020 Pages: 264 - 264

24. Correction to: Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expression

    • Naoki Tamura
    • Hirona Maeda
    • Akifumi Takaori‑Kondo

    Correction 28 June 2020 Pages: 265 - 265